Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.
about
Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein sivaMolecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3Diagnosing and treating active myocarditisMyocardial diseases of animalsViral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and managementDetection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis.Role of autoimmunity in dilated cardiomyopathygamma delta+ T cells regulate major histocompatibility complex class II(IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditisRoles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and coxsackievirus B3-induced myocarditis.Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response.Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis.Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis.Noninvasive assessment of cardiac abnormalities in experimental autoimmune myocarditis by magnetic resonance microscopy imaging in the mouse.Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.Verapamil ameliorates the clinical and pathological course of murine myocarditisApolipoprotein J/clusterin induction in myocarditis: A localized response gene to myocardial injuryExperimental influenza A virus myocarditis in mice. Light and electron microscopic, virologic, and hemodynamic study.Coxsackievirus-induced disease. CD4+ cells initiate both myocarditis and pancreatitis in DBA/2 mice.Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy.Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice.Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice.Coxsackievirus B-3 myocarditis. T-cell autoimmunity to heart antigens is resistant to cyclosporin-A treatmentContrasting features of T-lymphocyte-mediated diabetes in encephalomyocarditis virus-infected Balb/cBy and Balb/cCum mice.Antigen-specific suppressor T cells prevent cardiac injury in Balb/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditisCoxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes.Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanismsIn situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice.A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.IL-21R expression on CD8+ T cells promotes CD8+ T cell activation in coxsackievirus B3 induced myocarditisHeart-specific autoantibodies following murine coxsackievirus B3 myocarditisDifferential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3Clinical and experimental aspects of viral myocarditis.Selection of an attenuated Coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen.Functional diversity in vascular endothelial cells: role in coxsackievirus tropism.An attenuated variant of Coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo
P2860
Q24524880-1FC73134-DEF0-496A-A609-B7D59457B1F2Q24537348-AF090ACA-0E8E-4DF3-84B0-5C9CB216C07EQ27335025-35FF241B-8F33-45D0-A831-B8EF44F1C069Q27469321-5A7DDABF-C340-4F4E-A574-F51C84F86BE7Q27478460-D32E51E0-929B-462A-A22B-B7E4B3BBDA24Q28345278-D09617EA-2E41-4F39-BCDD-2F090CE13FE2Q33562609-222D44F4-2D19-444B-9C86-3A3AC7CE68F1Q33614482-89254C10-B550-4733-A759-A1C65E7C9043Q33815399-9BFCD8F2-7595-424F-80DD-C9344E5F3F24Q33833868-6DD75DBF-B837-49F0-BD2E-8B353A687CC2Q33833988-B51EB2E2-1F5A-42BB-BA53-4EE51628DDC9Q33837835-CB71E97C-C87B-4BBE-9E3A-209E4BAFB682Q33842268-632635EB-605D-430C-805E-8B4D85034CB6Q34371898-356CF7DC-4947-4EB9-A2FD-338A87EB64DAQ34550454-4B116F85-3800-4AC7-A940-69D2EB2A0854Q34608956-43D05CD3-D500-429E-B8DF-0638F0ECC75DQ35483420-0AB928DA-1F34-448C-BF1D-D94FCA72702CQ35609065-835B7750-38DB-4844-A81A-3551E0C93521Q35774032-EB68DC48-B0A7-4E63-ABF6-E0518D6639F5Q35811133-939E4180-C51B-4997-B469-9E34F577CE73Q35817347-FCB1EB3B-7E02-4D72-BEFF-CEF8531D857DQ35830424-3A1C4E5A-E088-4734-9E20-055200E7C91FQ35831868-843235D5-F96C-4E7A-A2E3-A457A9EC1A63Q35835669-A1843C34-C704-4D67-8598-8430D9359211Q35836028-C124E68A-78AB-4409-8CC4-A5E9AB7DD01DQ35836113-FBE92970-4ACA-4CB4-B69A-138016DF7A8FQ35836596-6468A3BD-DECF-41F7-9100-C4D5DDF56B5DQ35849766-47A5DB91-E1AB-4A51-BABB-14E28E89E3C2Q35856085-15AFE8AD-075C-4860-B3C5-C4259B336278Q35856170-703B2C67-CA66-4D4F-9E77-144B69380BFEQ35856321-D7B7B4FC-52AD-4F07-B378-514D17CE9C5AQ35856405-C1EC80BE-29EE-40C4-A215-2EFB3681AFC5Q35872223-56BA8EE4-5C64-46B2-927D-191F01907892Q35965698-70060EF4-02A5-4DB9-93B3-E2CEF85A490EQ36350046-85C77302-C9F0-4B4C-9F3D-373B0424F407Q36625352-B9635568-3EC8-495A-9589-42A3D8D3442EQ36635072-A134FB2C-7515-4BC0-A2D2-49757856BD3DQ36682025-B1E0E142-0513-4B0B-928E-3FC5F9F1F286Q36783251-C1DE7F8F-1391-475F-8D8D-1D3648270536Q36820749-80484046-6C22-47C2-B07B-140BAC7CDF90
P2860
Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Coxsackievirus B-3 myocarditis ...... oimmunity to myocyte antigens.
@ast
Coxsackievirus B-3 myocarditis ...... oimmunity to myocyte antigens.
@en
type
label
Coxsackievirus B-3 myocarditis ...... oimmunity to myocyte antigens.
@ast
Coxsackievirus B-3 myocarditis ...... oimmunity to myocyte antigens.
@en
prefLabel
Coxsackievirus B-3 myocarditis ...... oimmunity to myocyte antigens.
@ast
Coxsackievirus B-3 myocarditis ...... oimmunity to myocyte antigens.
@en
P2860
P1476
Coxsackievirus B-3 myocarditis ...... oimmunity to myocyte antigens.
@en
P2093
P2860
P407
P577
1984-07-01T00:00:00Z